Naturally occurring and synthetic agents as potential anti-inflammatory and immunomodulants

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 11, Issue 1, 2012, Pages 3-19

  Sultana, Nighat ^a   Saify, Zafar Saeed ^b  

^a PCSIR LABORATORIES COMPLEX   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Anti inflammatory; Immunomodulators; Natural anti inflammatory medicine; Synthetic compounds; Terpenes; Triterpene esters

Indexed keywords

ALPHA AMYRIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETULIC ACID; CELECOXIB; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; IMMUNOMODULATING AGENT; INDOMETACIN; KETOPROFEN; KETOROLAC TROMETAMOL; LUPEOL ACETATE; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; OLEANOLIC ACID DERIVATIVE; OXAPROZIN; PLANT EXTRACT; TERPENE DERIVATIVE; TRITERPENOID; UNINDEXED DRUG; URSOLIC ACID DERIVATIVE;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CHINESE MEDICINE; DRUG POTENCY; DRUG STRUCTURE; ETHNOPHARMACOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MARINE SPECIES; MEDICINAL PLANT; NONHUMAN; REVIEW; TRADITIONAL MEDICINE;

EID: 84867523782     PISSN: 18715230     EISSN: 1875614X     Source Type: Journal    
DOI: 10.2174/187152312803476264     Document Type: Review

References (165)

1. Onwuchekwa, C., Oluwole, F.S. Anti-gastric ulcer and antiinflammatory properties of betulinic acid in male Albino rats. Science World J., 2010, 5(4), 15-17.
2. Sultana N., and Saleem M. Phytochemical studies on Alstonia scholaris. Zeitschrift fur Naturforsch, 2010, 65(B), 203-210.
3. Sultana, N., Ata, A. Oleanolic acid and related derevatives as medicinally important compounds. J. Enzy. Inhib. Med. Chem., 2008, 23(6), 739-56.
4. Sultana, N., Clinically useful anticancer, antitumor and antiwrinkle agent, ursolic acid and related derevatives as medicinally important natural product. J. Enzym. Inhib. Med. Chem., 2011, 26(5), 616-642.
5. Sultana, N., Saify, Z.S. Enzymatic Biotransformation of terpenes as bioactive agents, J. Enzym. Inhib. Med. Chem., (April 2012, acknowledged).
6. Coussens, L.M., Werb, Z. Inflammation and cancer. Nature, 2002, 420, 860-867.
7. Karin, M.; Cao, Y.; Greten, F.R.; Li, Z.W. NF-kappa;B in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer, 2002, 2, 301-310.
8. Hayden, M.S., Ghosh, S. Signaling to NF-kappB. Genes Dev. 2004, 18, 2195-2224.
9. Janssens, S., Tschopp, J. Signals from within: The DNA-damageinduced NF-kappaB response. Cell Death Differ., 2006, 13, 773-784.
10. Karin, M., Greten, F.R., NF-kappaB. linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5, 749-759.
11. Bonizzi, G., Karin, M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25, 280-288.
12. Kumar, A., Takada, Y., Boriek, A.M. Aggarwal, B.B. Nuclear factor-kappa B: its role in health and disease. J. Mol. Med., 2004, 82, 434-448.
13. Aggarwal, B.B.; Vijayalekshmi, R.V.; Sung, B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res., 2009, 15, 425-430.
14. Xie, K., Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev., 2001, 12, 375-391.
15. Garg, A.; Aggarwal, B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia, 2002, 16, 1053-1068.
16. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420, 860-867.
17. Nathan, C. Points of control in inflammation. Nature, 2002, 420, 846-852.
18. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 2005, 7, 211-217.
19. Ulrich, C.M.; Potter, J. D. Testing for colon neoplasia susceptibility variants at the human Cox 2 locus. J. Natl. Cancer Inst., 2001, 93, 1572-1574.
20. Tian, Z., Yang, M., Huang, F., Li, K., Si, J.; Shi, L.; Chen, S.; Xiao, P. Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica. Cancer Lett., 2005, 226, 65-75.
21. Whitehouse, M.W. Some biochemical and pharmacological properties of anti-inflammatory drugs, Progress in Drug Research, 1965, 8, 321.
22. Pakrashi, S.C., Herbal drugs, nutraceuticals and rural health. Tenth Asian symposium on medicinal plants, species and other natural products, Dhaka, Bangladesh, 2000, p.63.
23. Gilani, A.H., Rahman, A. Trends in ethnopharmacology. J. Ethnopharmacol, 2005, 100: 43-49.
24. Rahman, A. Discovery of bioactive compounds from medicinal plants. Tenth Asain symposium on medicinal plants, species and other natural products. Dhaka, Bangladesh, 2000, p.3.
25. Farnsworth, N.R. The role of ethnopharmacology in drug development. In: Bioactive compounds from plants (Chadwick, D. J., Marsh, J., Eds.), CIBA foundation symposium 154, John Wiley and Sons Ltd., Chichester, 1990, pp. 2-21.
26. Cragg, G.M., Newman, D.J., Snader, K.M. Natural products in drug discovery and development. J. Nat. Prod., 1997, 60, 52-60.
27. Gilani, A.H.; Molla, N.; Atta-ur-Rahman, Shah, B. H. Role of natural products in medicine. J. Pharmaceutic. Med., 1992, 2, 111-118.
28. Patwardhan, B., Vaidya, A.B.D., Chorghade M. Ayurveda and natural products drug discovery. Current Science, 2004, 86(6), 789-799.
29. Steinmeyer, J. Pharmacological basis for the therapy of pain and inflammation with non sterodial anti-inflammatory drugs. Arthritis Res., 2000, 2, 379-385.
30. Kosjek, T., Heath, E., Krbavcic, A. Determination of non-steroidal anti-inflammatory drug residues in water samples. Environment International, 2005, 31, 679-685
31. Ammon, H.P.T., Mack, T., Singh, G.B., Safayhi, H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of gum resin exudate of Boswellia serrata, Planta Med., 1991, 57, 203-207.
32. Ammon, H.P.T.; Anazodo, M.I.; Safayhi, H.; Dhawan, B.N., Srimal, R.C. Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorpho nuclear neutrophils (PMNL). Planta Med., 1992, 58, 226.
33. Li, R.W.; Leach, D.N.; Myers, S.P.; Lin, G.D.; Leach, G.J.; Waterman, P.G. A new anti-inflammatory glucoside from Ficus racemosa L. Planta Med., 2004, 70, 421-426.
34. Singh, G.; Ramey, D.R.; Morfeld, D.; Hatoum, H.T.; Fries, J.F. Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis. A prospective observational short study. Arch. Intern. Med., 1996, 156, 1530-1536.
35. Kelm, M.A.; Nair, M.G.; Strasburg, G.M.; DeWitt, D.L. Antioxidant and cyclooygenase inhibitory phenolic compounds from Ocimum Sanctum Linn. Phytomedicine, 2000, 7, 7-13.
36. Albert, D.; Zundrof, I.; Dingermann, T.; Muller, W.E.; Steinhilber, D.; Werz, O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem. Pharmacol, 2002, 64, 1767-1775.
37. Calixto, J.B.; Otuki, M.F.; Santos, A.R.S. Anti-inflammatory compounds of plant origin. Part L. Action on arachidonic acid pathway, nitric oxide and nuclear factors kB (NF-kB). Planta Med., 2003, 69, 973-983.
38. Borchers, A.T.; Keen, C.L.; Stern, J.S.; Gershwin, M.E. Inflammation and native American medicine: the role of botanicals. Am. J. Clin. Nutrit., 2000, 72, 339-347.
39. Davis, R.H.; Paker, W.L.; Murdoch, D.P. Aloe vera as biologically active vehicle for hydrocortisone acetate. J. Am. Podiatric Association, 1991, 81, 1-9.
40. Davis, R.H.; Leitner, M.G.; Russo, J.M.; Byrne, M.E. Wound healing. Oral and topical activity of Aloe vera. J. Am. Podiatric Association, 1989, 79, 559-562.
41. Bluden, G. Review, biologically active compounds from marine organisms. Phytother. Res., 2001, 15, 89-94.
42. Guzman, S.; Gato, A.; Calleja, J.M. Anti-inflammatory, analgesic and free radical scavenging activities of the marine micro algae Chlorella stigmatophora and Phaeodactylum tricornutum. Phytother. Res., 2001, 224-230.
43. Lucas, R.; Giannini, C.; D'Auria, M.V.; Paya, M. Modulatory effect of bolinaquine, a marine sesquiterpenoid on acute and chronic inflammatory processes. J. Pharmacol. Exp.Ther., 2003, 304, 1172-1180.
44. Altman, R.D.; Marcussen, K.C. Effect of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum., 2001, 44, 2531-2538.
45. Halliwell, B. Antioxidant characterization. Methodology and mechanism. Biochem. Pharmacol., 1995, 49, 1341-1348.
46. Cuzzocrea, S.; Zingarelli, B.; Constantino, G.; Szabo, A.L.; Caputi, A.P.; Szabo, C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in the rat model of splanchie artery occlusion and reperfusion. Br. J. Pharmacol., 1997, 121, 1065-1074.
47. Salvemini, D.; Masferrer, J.L. Interactions of nitric oxide with cyclooxygenase; in vitro, ex vitro, and in vivo studies. Methods enzymol., 1996, 269, 12-25.
48. Cuzzocrea, S.; Riley, D.P.; Caputi, A.P.; Salvemini, D. Antioxidant therapy: A new pharamacolgical approach in shock, inflammation and ischemia/reperfusion injury. Pharmacol. Rev., 2001, 53, 135-159.
49. Vaya, J.; Aviram, M. Nutritional antioxidants: Mechanism of action, analyses of activities and medical applications. Curr. Med. Chem.-fmm. Endoc. Metab. Agents, 2001, 1: 99-117.
50. Ivanova, E.; Ivanov, B. Mechanisms of the extracellular antioxidant defend. Exp. Pathol. Parasitol., 2000, 4, 49-59.
51. Krinsky, N.I. Mechanism of action of biological antioxidants. Proc. Soc. Exp. Biol. Med., 1992, 200, 248-254.
52. Upasani, C.D.; Balaraman, R. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother. Res., 2003, 17, 330-334.
53. Halliwell, B.; Gutteridge, J.B. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys., 1990, 280, 1-8.
54. Ivanova, E.; Ivanov, B. Mechanisms of the extracellular antioxidant defend. Exp. Pathol. Parasitol., 2000, 4: 49-59.
55. Perez-Garcia, F.; Canigueral, S.; Adzet, T. Anti-inflammatory action of Pluchea saguttalis: involvement of an antioxidant mechanism. Life Sci., 1996, 59, 2033-2040.
56. Salvemini, D.; Mazzon, E.; Dugo, L.; Riley, D.P.; Serriano, L; Caputi, A.P.; Cuzzuocrea, S. Pharamacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br. J. Pharmacol., 2001, 132, 815-827.
57. Greenwald, R.A. Superoxide dismutase and catalase as therapeutic agents for human disease. Free Rad. Biol. Med., 1990, 8, 201-209.
58. Trenam, C.W.; Blake, D.R.; Morris, C.J. Skin in flammation reactive oxygen species and the role of iron. J.Invest. Dermatol., 1992, 99, 675-682.
59. Sco, H.G.; Takakata, I.; Nakamura, M.; Tatsumi, H.; Suzuki, K.; Jugi, J.; Tanigushi, N. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutase in experiment colitis in rats. Archs. Biochem. Biophys., 1995, 324, 41-47.
60. Wu, S.J.; Tsai, J.Y.; Chang, S.P.; Lin, D.L.; Wang, S.S.; Huang, S.N.; Ng, L.T. Supercritical carbon dioxide extract exbihits enhanced antioxidant and anti-inflammatory activities of Physalis peruviana, J. Ethnopharmacol., 2006, 108, 407-413.
61. Wiseman, H.; Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J., 1996, 313, 17-29.
62. Witzum, J.L. Oxidative hypothesis of atheroscelerosis. Lancel, 1994, 344, 793-795.
63. Leboritz, R.L.; Zhang, H.; Vogel, H.; Catwright, J.; Jr. Dionne, L.; Lu, N.; Husang, S.; Matzk, M.M. Neurodegeneration, myocardial injury and perinatal death in mitochondrial superoxide dismutasedeficient mice. Proc. Natl. Acad. Sci. USA., 1996, 93, 9782-9787.
64. Jenner, P. Oxidative damage in neurodegenerative disease. Lancel, 1994, 344, 796-798.
65. Halliwell, B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann. Rheum. Dis., 1995, 54, 505-510.
66. Orr, W.C.; Sohal, R.S. Extention of life-span by over expression of superoxide dismutase and catalase in Drosophlia melannegoster. Science, 1994, 263, 1128-1130.
67. Jian, A.; Basal, E. Inhibition of Propionibacterium acnes-induced mediators of inflammatory by Indian herbs. Phytomedicine, 2003, 10, 34-38.
68. Aitken, J.; Fisher, H. Reactive oxygen species generation and human spermatozoa: The balance of benefit and risk. Bioassays, 1994, 16, 259-267.
69. Squadriato, G.L.; Peyor, W.A. Oxidative chemistry of nitric oxide: The role of superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol. Med., 1998, 25, 392-403.
70. Chae, S.; Kim, J.S.; Kang, K.A.; Bu, H.D.; Lee, Y.; Hyun, J.W. and Kang, S.S. Antioxidant activity of Jionoside D from Clerodendron trichotomum. Biol. Pharm. Bull., 2004, 27, 1504-1508.
71. McCord, J.M.; Omar, B.A. Sources of free radicals. Toxicol. Industrial Health, 1993, 9, 23-37.
72. Kerr, M.E.; Bender C.M.; Monti, E.J. An introduction to oxygen free radicals. Heart Lung, 1996, 25, 2000-209.
73. Gulein, I.; Buyukokuroglu, M. E.; Okaty, M.; Kufrevioglu, I.O. Antioxidant and analgesic activities of turpentine of Pinus nigar Arn. Subsp. Pallsiana (Lamb.). Holmboe, J. Ethnopharmacol., 2003, 86, 51-58.
74. Bakonyi, T.; Radak, Z. High altitude and free radicals. J. Sports Sci. Med., 2004, 3, 64-69.
75. Chanock, S.J.; Benna, J.E. The respiratory burst oxidase. J. Biol. Chem., 1994, 269, 24519-24522.
76. Kawakami, N.; Koyama, Y.; Tanaka, J.; Ohara, A.; Hayakawa, T.; Fujimoto, S. Inhibitory effect of acetylshikonin on the activation of NADPH oxidase in polymorphonuclear leukocytes in both whole cell-free system. Biol. Pharm. Bult. 1996, 19: 1266-1270.
77. Takemasa, H.; Imagawa, N.; Kawakami-Honda, N.; Nagasawa, K.; Fujimoto, S. Effect of phosphotyrosine proteins on phorbol myristate acetate-induced NADPH oxidase activation in juinea pig peritoneal polymorphonuclear leukocytes. Biol. Pharm. Bull., 2003, 26, 1009-1012.
78. McCord, J.M.; Omar, B.A. Sources of free radicals. Toxicol Industrial Health, 1993, 9: 23-37.
79. Prigmore, E.; Ahmed, S.; Best, A.; Kozma, R.; Manser, E.; Segal, A.W.; Lim, L. A 68-kDa kinase and NADPH oxidase component p67phox are targets for Cdc42Hs and Rac1 in neutrophils. J. Biol. Chem., 1995, 270, 10717-10722.
80. Poli, G.; Leonarduzzi, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signaling. Curr. Med. Chem., 2004, 11, 1163-1182.
81. Cheesman, K.H.; Slater, T.F. An introduction to free radical biochemistry. Br. Med. Bull., 1993, 49, 481-493.
82. McCormick, M.L.; Buettner, G.R.; Britigan, B.E. Endogenous superoxide dismutase levels regulate iron-dependent hydroxyl radical formation in Echerichia coli exposed to hydrogen peroxide. J. Bacteriol., 1998, 180, 622-625.
83. Mello-Filho, A.C.; Meneghini, R. In vino formation of singlestrand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim. Biophys. Acta, 1984, 781, 56-63.
84. Dizdraoglu, M.; Rao, G.; Halliwell, B.; Gajewki, E. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem, Biophys., 1991, 285, 317-324.
85. Halliwell, B.; Gutteridge, M.C. Biologically relevant metal iondependent hydroxyl radical generation: An update. FEBS Lett., 1992, 307, 108-112.
86. Grace, S.C.; Salgo, M.G.; Pryor, W.A. Scavenging of peroxynitrite by a phenolic/ peroxidase system prevents oxidative damage to DNA. FEBS Letters, 1998, 426, 24-28.
87. Ivanova, E.; Ivanov, B. Mechanisms of the extracellular antioxidant defend. Exp. Pathol. Parasitol., 2000, 4, 49-59.
88. Cheeseman, K.H. Mechanisms and effects of lipid peroxidation. Mol. Aspects Med., 1993, 14: 191-197.
89. Schafer, F.Q.; Qian, S.Y.; Buettner, G.R., Iron and free radical oxidations in cell membranes. Cellular. Mol. Biol., 2000, 46, 657-662.
90. Aitken, J.; Fisher, H. Reactive oxygen species generation and human spermatozoa: the balance of benefit and risk. Bioessays, 1994, 16(4), 259-67.
91. Suh, N.; Wang, Y.; Honda, T.; Gribble, G.W.; Dmitrovsky, E.; Hickey, W.F.; Maue, R. A.; Place, A. E.; Porter, D.M.; Spinella, M.J.; Williams, C.R.; Wu, G.; Dannenberg, A. J.; Flanders, K.C.; Letterio, J.J.; Mangelsdorf, D.J.; Nathan, C.F.; Nguyen, L.; Porter, W. W.; Ren, R.F.; Roberts, Toxins, 2010, 2, 2462.
92. Roche, A.B., Subbaramaiah, N.S., Sporn, M.B.K. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1, 9-dien-28-oic acid, with potent differentiating, antiproliferative, and antiinflammatory activity. Cancer Res. 1999, 59, 336-341.
93. Suh, N.; Roberts, A.B.; Birkey Reffey, S.; Miyazono, K.; Itoh, S.; Ten Dijke, P., Heiss, E.H.; Place, A.E.; Risingsong, R.; Williams, C.R.; Honda, T., Gribble, G.W.; Sporn, M.B. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Cancer Res. 2003, 63, 1371-1376.
94. Suh, W.S.; Kim, Y.S.; Schimmer, A.D.; Kitada, S.; Minden, M.; Andreeff, M.; Suh, N.; Sporn, M.; Reed, J.C. Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving down regulation of FLIP and sensitization to TRAIL. Leukemia, 2003, 17, 2122-2129.
95. Haridas, V.; Kim, S.O.; Nishimura, G.; Hausladen, A.; Stamler, J.S.; Gutterman, J.U. Avicinylation (thioesterification): A protein modification that can regulate the response to oxidative and nitrosative stress. Proc. Natl. Acad. Sci. USA, 2005, 102, 10088-10093.
96. Haridas, V.; Arntzen, C.J.; Gutterman, J.U. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-kappaB by inhibiting both its nuclear localization and ability to bind DNA. Proc. Natl. Acad. Sci. USA, 2001, 98, 11557-11562.
97. Dirsch, V.M.; Kiemer, A.K.; Wagner, H.; Vollmar, A.M. The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages. Eur. J. Pharmacol. 1997, 336, 211-217.
98. Syrovets, T.; Buchele, B.; Krauss, C.; Laumonnier, Y.; Simmet, T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNFalpha induction in monocytes by direct interaction with Ikappa B kinases. J. Immunol, 2005, 174, 498-506.
99. Deeb, D.; Gao, X.; Jiang, H.; Dulchavsky, S.A.; Gautam, S.C. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting prosurvival Akt and mTOR. Prostate, 2009, 69, 851-860.
100. Huang, L.; Guan, T.; Qian, Y.; Huang, M.; Tang, X.; Li, Y.; Sun, H. Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factorkappa B., Eu. J. Pharmacol., 2011, 672, 1-3, 15.
101. Won, J.H., Shin, J.S.; Park, H.J., Jung, H.J., Koh, D.J.; Jo, B.G., Lee, J.Y., Yun, K., Lee, K.T., Anti-inflammatory Effects of Madecassic Acid via the Suppression of NF-kappaB Pathway in LPSInduced RAW 264.7 Macrophage Cells. Planta Med. 2010, 76, 251-257.
102. Brunelleschi, S.; Bardelli, C.; Amoruso, A.; Gunella, G.; Ieri, F.; Romani, A.; Malorni, W.; Franconi, F. Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappa B translocation in human monocyte/macrophages. Pharmacol. Res. 2007, 56, 542-549.
103. Shishodia, S.; Aggarwal, B.B. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene, 2006, 25, 1463-1473.
104. Ichikawa, H.; Takada, Y.; Shishodia, S.; Jayaprakasam, B.; Nair, M.G.; Aggarwal, B.B. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaBregulated gene expression. Mol. Cancer Ther., 2006, 5, 1434-1445.
105. Ruikar, A.D; Misar, A.V.; Jadhav, R.B.; Rojatkar, S.R.; Mujumdar, A.M.; Puranik, V.G.; Deshpande, N.R. Sesquiterpene lactone, a potent drug molecule from Artemisia pallens wall withantiinflammatory activity. Arzneimittel Forschung, 2011, 61(9), 510-514.
106. Syrovets, T.; Buchele, B.; Krauss, C.; Laumonnier, Y.; Simmet, T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNFalpha induction in monocytes by direct interaction with Ikappa B kinases. J. Immunol, 2005, 174, 498-506.
107. Lee, J.H.; Koo, T.H.; Yoon, H.; Jung, H.S.; Jin, H.Z.; Lee, K.; Hong, Y.S.; Lee, J.J. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem. Pharmacol, 2006, 72, 1311-1321.
108. Yesilada, E.; Bedir, E.; Calis, I.; Takaishi, Y.; Ohmoto, Y. Effects of triterpene saponins from Astragalus species on in vitro cytokine release, J. Ethnopharmacol. 2005, 96, 71-77.
109. Chang, U.M.; Li, C.H.; Lin, L.I.; Huang, C.P.; Kan, L.S.; Lin, S.B.; Ganoderiol F. A ganoderma triterpene, induces senescence in hepatoma HepG2 cells, Life Sci. 2006, 79, 1129-1139.
110. Lu, K.W.; Tsai, M.L.; Chen, J.C.; Hsu, S.C.; Hsia, T.C.; Lin, M.W.; Huang, A. C.; Chang, Y.H.; Ip, S.W.; Lu, H.F.; Chung, J.G. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9. Anticancer Res., 2008, 28, 1093-1099.
111. Saraswati S.; Pandey M.; Mathur R.; Agrawal S.S. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model. Microvasc Res., 2011, 82 (3), 263-8.
112. Syrovets, T.; Gschwend, J.E.; Buchele, B.; Laumonnier, Y.; Zugmaier, W.; Genze, F.; Simmet, T. Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgenindependent PC-3 prostate cancer cells in vitro and in vivo. J. Biol. Chem., 2005, 280, 6170-6180.
113. Takada, Y.; Ichikawa, H.; Badmaev, V.; Aggarwal, B.B. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J. Immunol. 2006, 176, 3127-3140.
114. Park, Y.S.; Lee, J.H.; Bondar, J.; Harwalkar, J.A.; Safayhi, H.; Golubic, M. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells. Planta Med. 2002, 68, 397-401.
115. Lee, K.J.; Hwang, S.J.; Choi, J.H.; Jeong, H.G. Saponins derived from the roots of Platycodon grandiflorum inhibit HT-1080 cell invasion and MMPs activities: Regulation of NF-kappaB activation via ROS signal pathway. Cancer Lett., 2008, 268, 233-243.
116. Lee, J.H.; Koo, T.H.; Yoon, H.; Jung, H.S.; Jin, H.Z.; Lee, K.; Hong, Y.S.; Lee, J.J. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem. Pharmacol., 2006, 72, 1311-1321.
117. Kim, M.O.; Moon, D.O.; Choi, Y.H.; Shin, D.Y., Kang, H.S.; Choi, B.T.; Lee, J.D.; Li, W.; Kim, G.Y. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells, Cancer Lett. 2008, 261, 98-107.
118. Xie, Y.; Ye, Y.P.; Sun, H.X.; Li, D. Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenintype saponins from the root of Platycodon grandiflorum. Vaccine, 2008, 26, 3452-3460.
119. Recio, M.C.; Giner, R.M.; Manez, S.; Gueho, J.; Julien, H.R.; Hostettmann, K.; Rios, J.L. Investigations on the steroidal antiinflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med., 1995, 61, 9.
120. Krogh, R.; Kroth, R.; Berti, C.; Madeira, A.O.; Sourza, M.M. Cechinel-Felho, V.; Delle-Monache, F.; Yunes, R.A. Isolation and identification of compounds with antinociceptive action from Ipomoea pes-caprae (L.) R. Br. Pharmazie, 1999, 54, 464.
121. Takada, Y.; Aggarwal, B.B. Betulinic acid suppresses carcinogeninduced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J. Immunol., 2003, 171, 3278-3286.
122. Tsai, J.C.; Peng, W.H.; Chiu T.H.; Lai S.C.; Lee C.Y. Antiinflammatory effects of Scoparia dulcis L. and betulinic acid. Am J. Chin Med., 2011, 39(5), 943-56.
123. Valencia, E.; Feria, M.; Díaz, J.G.; González, A.; Bermejo, J. Antinociceptive, anti-inflammatory and antipyretic effects of lapidin, a bicyclic sesquiterpene. Planta Med. 1994, 60 (5), 395-9.
124. Huang, G.J.; Pan, C.H.; Wu, C.H. Sclareol exhibits antiinflammatory activity in both lipopolysaccharide-stimulated macrophages and the γ-carrageenan-induced paw edema model. J. Nat. Prod., 2012, 27, 75(1), 54-9.
125. Shishodia, S.; Majumdar, S.; Banerjee, S.; Aggarwal, B.B. Ursolic acid inhibits nuclear factorkappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res., 2003, 63, 4375-4383.
126. Banno, N.; Akihisa, T.; Tokuda, H.; Yasukawa, K.; Higashihara, H.; Ukiya, M.; Watanabe, K.; Kimura, Y.; Hasegawa, J.; Nishino, H. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Biosci Biotechnol Biochem. 2004, 68, 85-90.
127. Tapondjou, L.A.; Lontsi, D.; Sondengam, B.L.; Choi, J.; Lee, K.T.; Jung, H.J.; Park, H.J. In vivo anti-nociceptive and antiinflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, from Cussonia bancoensis. Arch Pharm Res., 2003, 26, 143-6.
128. Ryu, S.Y.; Oak, M.H.; Yoon, S.K.; Cho, D.I.; Yoo, G.S.; Kim, T.S.; Kim, K.M. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris, Planta Med., 2000, 66, 358-60.
129. Tsuruga, T.; Chun, Y.; Ebizuka, Y.; Sankawa, U. Biologically active constituents of Melaleuca leucadendron: Inhibitors of induced histamine release from rat mast cells. Chem Pharm. Bull., 1991, 39, 3276-3278.
130. Quang, T.H.; Ngan, N.T.; Minh, C.V.; Kiem, P.V.; Nhiem, N.X.; Tai, B.H.; Thao, N.P.; Tung, N.H.; Song, S.B.; Kim, Y.H. Antiinflammatory triterpenoid Saponins from the Stem Bark of Kalopanax pictus, J. Nat. Prod., 2011, 74 (9), 1908-1915.
131. Hodges, L.D.; Kweifio-Okai, G., Macrides, T.A. Antiprotease effect of anti-inflammatory lupeol esters. Mol Cell Biochem, 2003, 252(1-2), 97-101.
132. Lucetti, D.L.; Lucetti, E.C.; Bandeira, M.A.; Veras, H.N.; Silva, A.H.; Leal, L.K.; Lopes, A.A.; Alves, V.C.; Silva, G.S.; Brito, G.A.; Viana, G.B. Anti-inflammatory effects andpossible mechanism of action of lupeol acetateisolated from Himatanthus drasticus(Mart.) Plumel J. Inflamm., (Lond), 2010, 7, 60.
133. Siddique, H.R.; Saleem, M. Beneficial health effects of lupeol triterpene: A review of preclinical studies. Life sciences, 2011, 285-293.
134. Huguet, A.; del Carmen Recio, M.; Máñez, S.; Giner, R.; Ríos, J. Effect of triterpenoids on the inflammation induced by protein kinase Cactivators, neuronally acting irritants and otheragents. Eur J. Pharmacol, 2000, 410 (1): 69-81.
135. Akihisa, T.; Kojima, N.; Kikuchi, T.; Yasukawa, K.; Tokuda, H.T.; Masters, E.; Manosroi, A.; Manosroi, J. Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from sheafat. J. Oleo Sci, 2010, 59 (6), 273-80.
136. Gallo, M.B.C.; Sarachine, M.J. Biological activities of Lupeol. Int. J. Biomed. Pharmaceutical Sci., 2009; 1, 46-66.
137. Akihisa, T.H.; Kojima, N.; Kikuchi, T.; Yasukawa, K.; Tokuda, H.; Masters, E.; Manosroi, A.; Jiradej, M. J. Oleo Sci., 2010, 59 (6), 273-280.
138. Singh, G.B.; Singh, S.; Bani, S.; Gupta, B.D.; Banerjee, S.K. Antiinflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol., 1992, 44 (5), 456-8.
139. Giner-Larza E.M.; Manez, S.; Recio, M.C.; Giner, R.M.; Prieto, J.M. Cerda-Nicolas, M.; Rios, J.L. Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J. Pharmacol. 2001, 428 (1): 137-43.
140. Gupta, M.B.; Bhalla, T.N.; Tangri, K.K.; Bhargava, K.P. Biochemical study of the anti-inflammatory activity of -α; and β-amyrin acetate. Biochem. Pharmacol., 1971, 20 (2), 401-405.
141. Ding, Y.; Liang, C.; Kim, J.H.; Lee, Y.-M.; Hyun, J.-H.; Kang, H.-K.; Kim, J.-A.; Min, B.S.; Kim, Y.H. Triterpene compounds isolated from Acer mandshuricum and their anti-inflammatory activity. Bioorg. Med. Chem. Lett., 2010, 20(5), 1528-1531.
142. Arulmozhi, S.; Mazumder, P.M.; Ashok, P.; Narayanan, L.S. Antinociceptive and anti-inflammatory activities of Alstonia scholaris Linn. R. Br. Pharmacognosy Mag., 2007, 3(10), 106-111.
143. Shang, J.H.; Cai, XH.; Feng, T.; Zhao, YL.; Wang, JK.; Zhang, LY.; Yan, M.; Luo, XD. Pharmacological evaluation of A. scholaris; Anti-inflammatory and analgesic effects. J. Ethnopharmacology, 2010, 129 (2), 174-81.
144. Karawya, M.S.; Ammar, N.R.; Hifnawy, M.S.; Al-Okbi, S.Y.; Mohamed, D.A.; El-Anssary, A.A. Phytochemical study and evaluation of the anti-inflammatory activity of some medicinal plants growing in Egypt. Med. J. Islamic World Acad. Sci., 2010, 18 (4), 139-150,
145. Nadinica, E.; Gorzalczanyb, S.; Rojoa, A.; van Barena, C.; Debenedettia, S.; Acevedo, U.C. Topical anti-inflammatory activity of Gentianella achalensis. Fitoterapia, 1999, 70, 166-171.
146. Zhang, M.; Iinuma, M.; Wang, J.-S.; Oyama, M.; Ito, T.; and Kong, L.-Y. Terpenoids from Chloranthus serratus and Their Antiinflammatory Activities, J. Nat. Prod., 2012, 75(4), 694-8.
147. Chan, S.T.; Pearce, A.N.; Januario, A.H.; Page, M.J.; Kaiser, M.; McLaughlin R.J.; Harper, J.L.; Webb, V.L.; Barker, D.; Copp, B.R. Anti-inflammatory and antimalarial meroterpenoids from the New Zealand ascidian Aplidium scabellum. J. Org. Chem., 2011, 76(21), 9151-6.
148. Cheng, X.; Zeng, Q.; Ren, J.; Qin, J.; Zhang, S.; Shen, Y.; Zhu, J.; Zhang, F.; Chang, R.; Zhu, Y.; Zhang, W.; Jin, H. Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents. Eur. J. Med. Chem., 2011, 46 (11), 5408-15.
149. Willoughby, D.A.; Boughton, B.; Spector, W.G. A lymph-node permeability factor in the tuberculin reaction. J. Path. Bact, 1964, 87, 353-363.
150. Scherrer, R.A.; Winter, C.V, Short F. W. The chemistry of nonsteroidal Anti-inflammatory agents. Abstracts 9th Medicinal Chemistry Symposium, Minneapolis, Minn., June 1964, pp. 1 la-i.
151. Shen, T.Y. 1965, International Symposium on Non-steroidal antiinflammatory Drugs, 1964, 5. Garattini and M. N. G. Dukes, Ed; International Congress Series No. 82; Excerpta Medica Foundation, 1965, p. 13.
152. Glenn, E.M.; Szmnszkovicz, J.; Heinzelman R.V.; Hester J.B. Jr, Youngdale G.A. Synthesis and anti-inflammatory activity of 2,3-bis (p-methoxyphenyl)indole and related compounds. J. Med. Chem., 1966, 9, 527-36.
153. Shen, T.Y. Topics in Medicinal Chemistry, Interscience published London, 1967, Vol.1.
154. Medawar, P.B. Lecturer on BBC, 1971.
155. Ottani, A.; Leone, S.; Sandrini, M.; Ferrari, A.; Bertolini, A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur. J. Pharmacol, 2006, 531, 280-281.
156. Dani, M.; Guindon, J.; Lambert, C.; Beaulieu, P. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur. J Pharmacol, 2007, 573 (1-3), 214-5.
157. Blower, AL.; Brooks, A.; Fenn, CG. NSAIDs and adverse effects at Bandolier, Non-steroidal anti-inflammatory drugs, Table 7.
158. Trelle, S.; Reichenbach, S.; Wandel, S.; Hildebrand, P.; Tschannen, B.; Villiger, P.M.; Egger, M.; Jüni, P. Cardiovascular safety of nonsteroidal anti-inflammatory drugs: Network meta-analysis. BMJ, 2011, 342, c7086.
159. Bao, F.; John, S.M.; Chen, Y.; Mathison, R.D.; Weaver, L.C. The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord, Neuroscience, 2006, 140(3), 1011-22.
160. Mathison R.D.; Befus, A.D.; Davison, J.S.; Woodman, R.C. Modulation of neutrophil function by the tripeptide feG. BMC Immunol, 2003, 4, 3.
161. Mathison, R.; Davison, J.S.; Befus, A.D. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors. Immunol Today, 1994, 15(11), 527-32.
162. Dery, R.E.; Mathison, R.; Davison, J.; Befus, A.D. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). Int Arch Allergy Immunol, 2001, 124(1-3), 201-4.
163. Dery, R.E.; Ulanova, M.; Puttagunta, L.; Stenton, G.R.; James, D.; Merani, S.; Mathison, R.; Davison, J.; Befus, A.D. Frontline: Inhibition of allergen-induced pulmonary inflammation by the tripeptide feG: A mimetic of a neuro-endocrine pathway. Eur. J. Immunol, 2004, 34(12), 3315-25.
164. Mathison, R.D.; Davison, J.S. The tripeptide feG regulates the production of intracellular reactive oxygen species by neutrophils. J. Inflamm. (Lond). 2006, 15, 3(1), 9.
165. Mathison, R.; Lo, P.; Tan, D.; Scott, B.; Davison, J.S. The tripeptide feG reduces endotoxin-provoked perturbation of intestinal motility and inflammation, Neurogastroenterol Motil. 2001, 13(6), 599-603.